Additionally, the decreased activity of AMPK has also been shown to participate in hypertension [48,66], lipid metabolism, inflammation [58], obesity, insulin resistance, type 2 diabetes [67], renal pathophysiology, aging [68], and tumor [68,69]. The gene discussed is PRKAA1; the disease is hypertensive disorder.